Contact Information
Company Information
Company
Theravance Biopharma US, Inc.
Annual Revenue
64381000.0
Technologies
AT&T DNS
Outlook
Microsoft Office 365
Google Cloud Hosting
Google Font API
Mobile Friendly
Nginx
UltiPro
reCAPTCHA
Google Tag Manager
WordPress.org
IoT
Remote
Keywords
lung disease
rare disease
dysautonomia
neurogenic orthostatic hypotension
biopharma
clinical research
drug development
biotechnology: pharmaceutical preparations
health care
respiratory diseases
neurologic diseases
pharmaceuticals
yupelri
revefenacin
copd treatment
medicines development
fda-approved drugs
clinical trials
investigational drugs
patient care
healthcare solutions
chronic obstructive pulmonary disease
norepinephrine reuptake inhibitors
drug discovery
global regulatory strategy
integrated team
innovative therapies
healthcare innovation
patient needs
clinical safety
healthcare investment
medicinal products
shareholder value
commercialization
drug approvals
healthcare benefits
corporate governance
biopharmaceuticals
medicinal development
clinical assets
onco-therapeutics
neurogenic conditions
market access
investor relations
healthcare policies
pharmaceutical innovation
drug pipeline
healthcare initiatives
safety & efficacy
patient-oriented solutions
clinical data
biopharma infrastructure
therapeutic areas
investment management
healthcare analytics
regulatory compliance
health
wellness & fitness
medical
hospital & health care
financial services
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans